Stephanie Bagully
Vice President, Cell & Gene Therapy at Syneos Health
Dr. Bagully has been leading global clinical research for 23+ years, with expertise in oncology, adoptive cell therapies, gene-modifying therapies, and novel mechanisms of action.
Dr. Bagully has been in leadership roles across small biotech and multiple large CROs, resulting in 4 approved products to date. Focused on bringing new therapies to patients in need, Dr. Bagully is considered a thought leader in how we can best meet the challenges of innovative patient care.
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312